Selection of 2'F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications.
about
Modified Nucleoside Triphosphates for In-vitro Selection TechniquesAptamers: A promising chemical antibody for cancer therapyGeneration of Aptamers with an Expanded Chemical RepertoireAcousto-microfluidics for screening of ssDNA aptamer.Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detection.Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
P2860
Selection of 2'F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Selection of 2'F-modified RNA ...... and therapeutic applications.
@en
type
label
Selection of 2'F-modified RNA ...... and therapeutic applications.
@en
prefLabel
Selection of 2'F-modified RNA ...... and therapeutic applications.
@en
P2860
P50
P1476
Selection of 2'F-modified RNA ...... and therapeutic applications.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00216-013-7350-Y
P407
P577
2013-09-17T00:00:00Z